AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50

Class I - Dangerous

What Should You Do?

  1. Check if you have this product:
    Lot #: 52217, Expiry: 04/18
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals
Reason for Recall:
Labeling: Incorrect Or Missing Package Insert: Product is labeled with unapproved labeling.
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

AMPICILLIN CAPSULES, USP, 250 mg, 500 count bottles, Rx only, Manufactured for: DAVA Pharmaceuticals, Inc., Fort Lee, NJ, By: Suir Pharma Ireland Ltd., Clonmel, Ireland, NDC: 67253-180-50

Product Codes/Lot Numbers:

Lot #: 52217, Expiry: 04/18

Distribution:

Distributed in: OH

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-1350-2015

Related Recalls